Role of Pyrimidine Depletion in the Mitochondrial Cardiotoxicity of Nucleoside Analogue Reverse Transcriptase Inhibitors
Role of Pyrimidine Depletion in the Mitochondrial Cardiotoxicity of Nucleoside Analogue Reverse Transcriptase Inhibitors
复制标题
嘧啶消耗在核苷类似物逆转录酶抑制剂线粒体心脏毒性中的作用
DOI:
10.1097/qai.0b013e3181f25946
复制
发表时间:
2010
期刊:
影响因子:
--
通讯作者:
UA. Walker
中科院分区:
文献类型:
--
作者:
K. Balcarek;D. Lebrecht;C. Deveaud;B. Beauvoid;J. Bonnet;JB. Kirschner;N. Venhoff;UA. Walker
Objective:Long-term antiretroviral treatment with nucleoside analogue reverse transcriptase inhibitors (NRTI) may result in a cardiomyopathy due to mitochondrial DNA (mtDNA) depletion. An intact mitochondrial function is required for the synthesis of intramyocardial pyrimidine nucleotides, which in turn are building blocks of mtDNA. We investigated if NRTI-related cardiomyopathy can be prevented with pyrimidine precursors.Methods:Mice were fed with zidovudine or zalcitabine with or without simultaneous Mitocnol, a dietary supplement with high uridine bioavailability. Myocardia were examined after 9 weeks.Results:Both NRTI induced a cardiomyopathy with mitochondrial enlargement, a disrupted cristal architecture on electron microscopy and diminished myocardial mtDNA copy numbers. The myocardial mtDNA-encoded cytochrome c-oxidase I subunit was impaired more profoundly than the nucleus-encoded cytochrome c-oxidase IV subunit. The myocardial formation of reactive oxygen species and mtDNA mutations was enhanced in zidovudine and zalcitabine treated animals. Mitocnol attenuated or normalized all myocardial pathology when given with both NRTI, but by itself had no intrinsic effects and no apparent adverse effects.Conclusions:Zidovudine and zalcitabine induce a mitochondrial cardiomyopathy, which is antagonized with uridine supplementation, implicating pyrimidine pool depletion in its pathogenesis. Pyrimidine pool replenishment may be exploited clinically because uridine is well tolerated.
登录
查看更多内容
影响因子:
1.2
作者:
U. Walker;N. Venhoff;E. C. Koch;M. Olschewski;Josef Schneider;B. Setzer
通讯作者:
B. Setzer
影响因子:
5
作者:
Lewis, William;Day, Brian J.;Copeland, William C.
通讯作者:
Copeland, William C.
影响因子:
56.9
作者:
SCHON, EA;RIZZUTO, R;DIMAURO, S
通讯作者:
DIMAURO, S
DOI:
10.1001/jama.1991.03470130092035
发表时间:
1991-10
期刊:
JAMA
影响因子:
--
作者:
M. Corral‐Debrinski;G. Stepien;J. Shoffner;M. Lott;K. Kanter;D. Wallace
通讯作者:
M. Corral‐Debrinski;G. Stepien;J. Shoffner;M. Lott;K. Kanter;D. Wallace
影响因子:
13.5
作者:
U. Walker;J. Bäuerle;M. Laguno;J. Murillas;S. Mauss;G. Schmutz;B. Setzer;R. Miquel;J. Gatell;J. Mallolas
通讯作者:
U. Walker;J. Bäuerle;M. Laguno;J. Murillas;S. Mauss;G. Schmutz;B. Setzer;R. Miquel;J. Gatell;J. Mallolas